PRQR - プロキュ―ア―ル・セラピュ―ティクス (ProQR Therapeutics N.V.)

PRQRのニュース

   ProQR Therapeutics Stock Is Trading Higher On Antisense Oligonucleotide Development Pact  2021/05/04 13:35:06 Benzinga
Yarrow Biotechnology Inc , a newly created company by RTW Investments LP , has in-licensed exclusive rights to ProQR Therapeutics N.V.'s (NASDAQ: PRQR ) antisense oligonucleotide technology to develop and commercialize potential therapies for an undisclosed non-ophthalmic target. Under the terms of the agreement, … Full story available on Benzinga.com
   Why PRQR Stock And APOP Stock Are Popping Off Today  2021/03/25 16:18:38 Benzinga
ProQR Therapeutics NV (NASDAQ: PRQR ) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge initially. ProQR is a biopharmaceutical … Full story available on Benzinga.com
   ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference  2020/12/18 12:00:00 GlobeNewswire
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated…
   ProQR Therapeutics Earnings and Growth Analysis : Stock market Insights & financial analysis  2020/11/04 20:53:00 Stock Market Daily
ProQR Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings  2020/10/21 12:04:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 20) Aileron Therapeutics Inc (NASDAQ: ALRN ) Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN ) Athira Pharma Inc (NASDAQ: ATHA ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI )( announced a reverse merger with Cytocom) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Immunomedics, Inc. (NASDAQ: IMMU ) Insmed Incorporated (NASDAQ: INSM ) Laboratory Corp. of America Holdings (NYSE: LH ) Pacific Biosciences of California Inc (NASDAQ: PACB ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 19) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Alector Inc (NASDAQ: ALEC ) Aligos Therapeutics Inc (NASDAQ: ALGS ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Baudax Bio Inc (NASDAQ: BXRX ) (issued a corporate update) Codiak BioSciences Inc (NASDAQ: CDAK ) (listed on Nasdaq on Oct. 14) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) FSD Pharma Inc (NASDAQ: HUGE ) Gilead Sciences, Inc. (NASDAQ: GILD ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ProQR Therapeutics NV (NASDAQ: PRQR ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Prothena to Advance Parkinson's Disease Drug Into Large-scale Confirmatory Study Prothena Corporation PLC (NASDAQ: PRTA ) said, based on positive signals of efficacy consistent with disease modification in the PASADENA study, it along with Roche Holdings AG Basel ADR Common Stock (OTC: RHHBY ) plans …
   Why PRQR Stock And APOP Stock Are Popping Off Today  2021/03/25 16:18:38 Benzinga
ProQR Therapeutics NV (NASDAQ: PRQR ) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge initially. ProQR is a biopharmaceutical … Full story available on Benzinga.com
   ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference  2020/12/18 12:00:00 GlobeNewswire
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated…
   ProQR Therapeutics Earnings and Growth Analysis : Stock market Insights & financial analysis  2020/11/04 20:53:00 Stock Market Daily
ProQR Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings  2020/10/21 12:04:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 20) Aileron Therapeutics Inc (NASDAQ: ALRN ) Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN ) Athira Pharma Inc (NASDAQ: ATHA ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI )( announced a reverse merger with Cytocom) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Immunomedics, Inc. (NASDAQ: IMMU ) Insmed Incorporated (NASDAQ: INSM ) Laboratory Corp. of America Holdings (NYSE: LH ) Pacific Biosciences of California Inc (NASDAQ: PACB ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 19) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Alector Inc (NASDAQ: ALEC ) Aligos Therapeutics Inc (NASDAQ: ALGS ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Baudax Bio Inc (NASDAQ: BXRX ) (issued a corporate update) Codiak BioSciences Inc (NASDAQ: CDAK ) (listed on Nasdaq on Oct. 14) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) FSD Pharma Inc (NASDAQ: HUGE ) Gilead Sciences, Inc. (NASDAQ: GILD ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ProQR Therapeutics NV (NASDAQ: PRQR ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Prothena to Advance Parkinson's Disease Drug Into Large-scale Confirmatory Study Prothena Corporation PLC (NASDAQ: PRTA ) said, based on positive signals of efficacy consistent with disease modification in the PASADENA study, it along with Roche Holdings AG Basel ADR Common Stock (OTC: RHHBY ) plans …
   The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs  2020/10/16 11:15:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 15) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Beam Therapeutics Inc (NASDAQ: BEAM ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Kronos Bio Inc (NASDAQ: KRON ) (IPOed Friday) Larimar Therapeutics Inc (NASDAQ: LRMR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Twist Bioscience Corp (NASDAQ: TWST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 15) ADC Therapeutics SA (NYSE: ADCT ) Alector Inc (NASDAQ: ALEC ) Artelo Biosciences Inc (NASDAQ: ARTL ) Aziyo Biologics Inc (NASDAQ: AZYO ) Codiak BioSciences Inc (NASDAQ: CDAK ) (listed on Nasdaq Wednesday) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Dyne Therapeutics Inc (NASDAQ: DYN ) Pandion Therapeutics Inc (NASDAQ: PAND ) ProQR Therapeutics NV (NASDAQ: PRQR ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Titan Pharmaceuticals, Inc. common stock (NASDAQ: TTNP ) (provided a strategic and corporate update) Uniqure NV (NASDAQ: QURE ) Stocks In Focus Zogenix Presents Data Showing Durability of Response For Seizure Drug Zogenix, Inc. (NASDAQ: ZGNX ) released interim data from open-label extension trial, showing substantial seizure reductions were maintained when treated with Fintepla oral solution for up to two years.

calendar